OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cost-effectiveness of digital therapeutics for essential hypertension
Akihiro Nomura, Tomoyuki Tanigawa, Kazuomi Kario, et al.
Hypertension Research (2022) Vol. 45, Iss. 10, pp. 1538-1548
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Recent advances in understanding dietary polyphenols protecting against hypertension
Zhongchao Gai, Songhao Hu, Guoli Gong, et al.
Trends in Food Science & Technology (2023) Vol. 138, pp. 685-696
Closed Access | Times Cited: 20

Anthocyanins as natural bioactives with anti-hypertensive and atherosclerotic potential: Health benefits and recent advances
Meili Xin, Aihua Xu, Jinlong Tian, et al.
Phytomedicine (2024) Vol. 132, pp. 155889-155889
Closed Access | Times Cited: 7

COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19
Shigeru Shibata, Kazuo Kobayashi, Masami Tanaka, et al.
Hypertension Research (2022) Vol. 46, Iss. 3, pp. 589-600
Open Access | Times Cited: 25

The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice
Kazuomi Kario, Noriko Harada, Ayako Okura
Hypertension Research (2022) Vol. 45, Iss. 12, pp. 1899-1905
Open Access | Times Cited: 21

Digital hypertension towards to the anticipation medicine
Kazuomi Kario
Hypertension Research (2023) Vol. 46, Iss. 11, pp. 2503-2512
Closed Access | Times Cited: 12

Understanding Digital Therapeutics in Disease Self-management: A Systematic Literature Review
Liang Yang, Manyang Zhang, Lin Jia, et al.
Technology in Society (2025), pp. 102831-102831
Closed Access

3D printing based soy protein isolate-flaxseed gum-catechin as a potential strategy to regulate hypertension
Dongbei Shen, Min Zhang, Arun S. Mujumdar, et al.
Food Bioscience (2025), pp. 106528-106528
Closed Access

Economic Evaluation Associated With Clinical-Grade Mobile App–Based Digital Therapeutic Interventions: Systematic Review
Yoann Sapanel, Xavier Tadeo, Connor T. A. Brenna, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e47094-e47094
Open Access | Times Cited: 9

Smartphone application-based intervention to lower blood pressure: a systematic review and meta-analysis
Makiko Abe, Tetsuo Hirata, Natsumi Morito, et al.
Hypertension Research (2024)
Closed Access | Times Cited: 3

Cost‐Effectiveness of Radiofrequency Renal Denervation for Uncontrolled Hypertension in Japan
Kazuomi Kario, Khoa N. Cao, Yuji Tanaka, et al.
Journal of Clinical Hypertension (2024) Vol. 26, Iss. 12, pp. 1502-1512
Open Access | Times Cited: 3

The dominant logic of Big Tech in healthcare and pharma
Alexander Schuhmacher, Naomi Haefner, Katharina Honsberg, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 2, pp. 103457-103457
Closed Access | Times Cited: 14

Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial
Masaya Sato, Masatoshi Akamatsu, Toshihide Shima, et al.
The American Journal of Gastroenterology (2022) Vol. 118, Iss. 8, pp. 1365-1372
Open Access | Times Cited: 12

Future of hypertension management through mobile applications
Takeshi Fujiwara, Katherine L. Tucker, Richard J. McManus
Hypertension Research (2024) Vol. 47, Iss. 4, pp. 1087-1089
Open Access | Times Cited: 2

Insights into insurance coverage for digital therapeutics: A qualitative study of US payer perspectives
Ainhoa Gómez-Lumbreras, Jason T. Hurwitz, Xi Liang, et al.
Journal of Managed Care & Specialty Pharmacy (2024) Vol. 30, Iss. 4, pp. 313-325
Open Access | Times Cited: 2

Digital therapeutics in hypertension: How to make sustainable lifestyle changes
Chaoyi Chen, Aiting Liu, Zhengzhipeng Zhang, et al.
Journal of Clinical Hypertension (2024) Vol. 26, Iss. 10, pp. 1125-1132
Open Access | Times Cited: 2

Adoption of Digital Therapeutics in Europe
Amelie Fassbender, Shaantanu Donde, Mitchell Silva, et al.
Therapeutics and Clinical Risk Management (2024) Vol. Volume 20, pp. 939-954
Open Access | Times Cited: 2

Economic Evaluation of Digital Therapeutic Care Apps for Unsupervised Treatment of Low Back Pain: Monte Carlo Simulation
Daniel Lewkowicz, Erwin P. Böttinger, Martin Siegel
JMIR mhealth and uhealth (2023) Vol. 11, pp. e44585-e44585
Open Access | Times Cited: 4

Cost-Effectiveness Analysis Comparing Conventional and Digital Software Supported Management for Hypothyroidism
Jung Hyun Kim, Jaeyong Shin, Man S. Kim, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 1

Digital therapeutics in Japan: Present and future directions
Akihiro Nomura
Journal of Cardiology (2024)
Open Access | Times Cited: 1

New wave of digital hypertension management for clinical applications
Hironori Nakagami
Hypertension Research (2022) Vol. 45, Iss. 10, pp. 1549-1551
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top